Fazadinium bromide
- Level
- Commodity
- Parent
- 51152000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51152029This classification denotes a nicotinic antagonist with the molecular formula C28H24N6.2Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8WV5538LFK, chemically known as 1,1-azobis(3-methyl-2-phenylimidazo(1,2-a)pyridinium) dibromide but generally known as fazadinium bromide, which bears US NIH Compound Identifier 5489112. European Medicines Agency schedules Fazadinium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07516MIG. The term FAZADINIUM BROMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules fazadinium bromide in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule fazadinium bromide under HS 29339990 and SITC 51577. As of Q4 2014, FAZADINIUM BROMIDE remains the US FDA Preferred Term for this commodity. Fazadinium bromide bears US NLM identifiers UMLS ID C0015707 and NCI Concept Code C80530. SMILES: Br.Br.N1(/N=N/n2c(C3CCCCC3)c([n]3c2cccc3)C)C(C2CCCCC2)C([n]2c1cccc2)C.
Same parent
Under 51152000 · 74Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.